Yue-Mei Yan

Identification and Validation of Key Genes Associated With Systemic Sclerosis-Related Pulmonary Hypertension

Ji-Na Zheng, Li Yang, Yue-Mei Yan et al. · Frontiers in Genetics · 2020 · 36 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +16

A randomized phase 2b study of subcutaneous PD-L1 antibody ASC22 in virally suppressed patients with chronic hepatitis B who are HBeAg-negative

Jiandan Qian, Yao Xie, Qianguo Mao et al. · Hepatology · 2024 · 22 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

ALT flares were linked to HBsAg reduction, seroclearance and seroconversion: interim results from a phase IIb study in chronic hepatitis B patients with 24-week treatment of subcutaneous PD-L1 Ab ASC22 (Envafolimab) plus nucleos (t)ide analogs

Guiqiang Wang, Yimin Cui, Yao Xie et al. · Journal of Hepatology · 2022 · 20 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Increased serum calpain activity is associated with HMGB1 levels in systemic sclerosis

Ji-Na Zheng, Yang Li, Yue-Mei Yan et al. · Arthritis Research & Therapy · 2020 · 18 citations · Full text

Life Sciences, Immunology, Molecular Biology +12

Myeloid cell-specific deletion of Capns1 prevents macrophage polarization toward the M1 phenotype and reduces interstitial lung disease in the bleomycin model of systemic sclerosis

Li Zhang, Yue-Mei Yan, Yong Yu et al. · Arthritis Research & Therapy · 2022 · 14 citations · Full text

Life Sciences, Immunology, Pathobiology +13